StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) bonds

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)

Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$202.90M
$0 due within a year
Net debt
-$261.20M
After $464.10M of cash
Implied interest rate
0.25%
FY2025 interest ÷ average debt
Interest coverage
1169.8×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in West Pharmaceutical Services's 10-Q for the period ended Sep 30, 2026

IssueCouponMaturesAmount issued
Series C notes, due July 5, 2027 (4.02%)4.02%Jul 5, 2027$73.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeAvailable
Revolving Credit Facility$500.00M$497.70M

See a number that looks wrong?